Cargando…
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of conditions that include steatohepatitis and fibrosis that are thought to emanate from hepatic steatosis. Few robust biomarkers or diagnostic tests have been developed for hepatic steatosis in the setting of obesity. We have developed...
Autores principales: | Wood, G. Craig, Chu, Xin, Argyropoulos, George, Benotti, Peter, Rolston, David, Mirshahi, Tooraj, Petrick, Anthony, Gabrielson, John, Carey, David J., DiStefano, Johanna K., Still, Christopher D., Gerhard, Glenn S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339694/ https://www.ncbi.nlm.nih.gov/pubmed/28266614 http://dx.doi.org/10.1038/srep43238 |
Ejemplares similares
-
CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
por: Chu, Xin, et al.
Publicado: (2018) -
Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long‐Term Risks of Congestive Heart Failure
por: Benotti, Peter N., et al.
Publicado: (2017) -
All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
por: Lent, Michelle R., et al.
Publicado: (2017) -
Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery
por: Still, Christopher D., et al.
Publicado: (2014) -
Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways
por: Gerhard, Glenn S., et al.
Publicado: (2018)